BIOVIC B — Biovica International AB Share News
0.000.00%
Last trade - 00:00- SEK86.11m
- SEK40.55m
- SEK13.38m
Brief: Biovica Gets Order Under Master Services Deal For Phase 1 Oncology Study
Brief: Biovica Resolves On Rights Issue Of SEK 29.2 Mln
Sweden's Biovica Q1 sales rise on Pharma Services growth
Brief: Biovica International Q1 Sales SEK 4.043 Million
Brief: Biovica Enters Master Services Agreement With Biotech Co
Brief: Biovica Gets Order Worth About $287,000
Brief: Biovica Signs Deal With U.S. Cancer Center
Brief: Biovica Gets Work Order Under Master Services Agreement
Brief: Biovica Expands Japanese Patent Protection
Brief: Biovica Receives Ninth Work Order From Customer
Brief: Biovica Appoints Maria Ekdahl As Chief Financial Officer
Brief: Biovica Expands Agreement With Current Customer
Brief: Biovica Gets Japanese Patent For Immuno-Oncology
Brief: Biovica Refocuses US Commercial Strategy, Terminates Deal With Tempus AI
Sweden's Biovica Q4 sales double, helping net loss narrow
Brief: Biovica International Q4 Sales SEK 4.815 Million
Brief: Biovica Gets Expanded Work Order From Clinical-Stage Oncology Company
Brief: Biovica International CFO Anders Morén resigns
Brief: Biovica: Theis Kipling To Assume Role As CEO